• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

Message to US colleagues

anonymous

Guest
Once upon a time - not so long ago - the US was the largest market for Galderma. These time are long gone. International, ie all markets ex-US now represent the bulk of sales and are growing at 13% whilst you are delivering 2.5%.
We’re all struggling with incompetent leadership and low morale. Please do better.